Baseline creatinine determination method impacts association between acute kidney injury and clinical outcomes

W Alton Russell1, David Scheinker1,2,3,4, Scott M Sutherland5,6

  • 1Department of Management Science and Engineering, Stanford University, Stanford, CA, USA.

Insights

Determining baseline serum creatinine significantly impacts acute kidney injury (AKI) detection and outcomes in children. Universal imputation may identify more clinically relevant AKI cases than empirical methods.

Area of Science:

  • Pediatric Nephrology
  • Clinical Chemistry
  • Biomarker Discovery

Background:

  • Current consensus definitions for acute kidney injury (AKI) lack standardized methods for determining baseline serum creatinine.
  • This ambiguity affects the accurate assessment of AKI incidence and its clinical implications.

Purpose of the Study:

  • To evaluate how different baseline serum creatinine determination methods influence AKI incidence in pediatric patients.
  • To assess the impact of these methods on the association between AKI and clinical outcomes, including mortality and chronic kidney disease.

Main Methods:

  • Retrospective analysis of pediatric patients discharged between 2014-2019.
  • Application of empirical (measured creatinine) and imputed (age/height-based equations) baseline estimation methods.
  • Assessment of AKI incidence and predictive accuracy (AUROC) for clinical outcomes: AKI billing code, inpatient mortality, and post-hospitalization CKD.

Main Results:

  • AKI incidence varied substantially (12.2-26.7%) across baseline methods.
  • Universal imputation of baseline creatinine improved AKI prediction for billing codes (AUROC 80.7-84.9%) compared to empirical methods (AUROC 64.5-76.6%).
  • Universal imputation also enhanced AKI prediction for post-hospitalization CKD (AUROC 67.0-74.6%), while empirical methods showed weak association (AUROC 46.4-58.5%). Baseline method did not impact mortality prediction.

Conclusions:

  • The method for determining baseline serum creatinine significantly influences AKI incidence and its association with clinical outcomes in pediatric patients.
  • Standardized criteria for baseline determination are crucial for consistent AKI diagnosis and management.
  • Universal imputation of baseline creatinine may identify a more clinically relevant AKI population, even when pre-admission values are available.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
175
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
344
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
525
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
90
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
88
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
295